| GRIA1 |
GRIA1, GLUH1, GLUR1: Glutamate receptor 1 precursor |
GRID2 |
GRID2: GRID2 protein |
3.705 |
Evidence |
|
| RPA2 |
RPA2, REPA2, RPA32, RPA34: Replication protein A 32 kDa subunit |
RPA3 |
RPA3, REPA3, RPA14: Replication protein A 14 kDa subunit |
3.705 |
Evidence |
|
| GRIK2 |
GRIK2, GLUR6: Glutamate receptor, ionotropic kainate 2 precursor |
GRID2 |
GRID2: GRID2 protein |
3.705 |
Evidence |
O
|
| S100B |
S100B: Protein S100-B |
S100A1 |
S100A1, S100A: Protein S100-A1 |
3.695 |
Evidence |
O
|
| BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
RAD51 |
RAD51, RAD51A, RECA: DNA repair protein RAD51 homolog 1 |
3.477 |
Evidence |
|
| CDK4 |
CDK4: Cell division protein kinase 4 |
SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
3.452 |
Evidence |
O
|
| PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
CRK |
IPI00399054 |
3.39 |
Evidence |
O
|
| CDC7 |
CDC7, CDC7L1: Cell division cycle 7-related protein kinase |
ORC6L |
ORC6L: Origin recognition complex subunit 6 |
3.362 |
Evidence |
O
|
| SOCS1 |
SOCS1, SSI1, TIP3: Suppressor of cytokine signaling 1 |
GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
3.317 |
Evidence |
|
| CAST1 |
ERC2, KIAA0378: ERC protein 2 |
PPFIA1 |
PPFIA1, LIP1: Liprin-alpha-1 |
3.317 |
Evidence |
|
| MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
ARAF |
ARAF, ARAF1, PKS, PKS2: A-Raf proto-oncogene serine/threonine-protein kinase |
3.285 |
Evidence |
O
|
| RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
PEBP1 |
PEBP1, PBP, PEBP: Phosphatidylethanolamine-binding protein 1 |
3.262 |
Evidence |
O
|
| CCNE2 |
CCNE2: G1/S-specific cyclin-E2 |
CDKN1A |
CDKN1A, CAP20, CDKN1, CIP1, MDA6, PIC1, SDI1, WAF1: Cyclin-dependent kinase inhi |
3.187 |
Evidence |
|
| NMI |
NMI: N-myc-interactor |
STAT3 |
|
3.187 |
Evidence |
|
| EIF2S2 |
EIF2S2, EIF2B: Eukaryotic translation initiation factor 2 subunit 2 |
CSNK2B |
CSNK2B, CK2N, G5A: Casein kinase II subunit beta |
3.107 |
Evidence |
|
| SOCS1 |
SOCS1, SSI1, TIP3: Suppressor of cytokine signaling 1 |
NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
3.055 |
Evidence |
O
|
| RRAGA |
RRAGA: Ras-related GTP-binding protein A |
RRAGC |
RRAGC: Ras-related GTP-binding protein C |
3.012 |
Evidence |
O
|
| APC |
IPI00215877 |
CTNNB1 |
CTNNB1, CTNNB, OK/SW-cl.35, PRO2286: Catenin beta-1 |
2.997 |
Evidence |
|
| SMARCA5 |
SMARCA5, SNF2H, WCRF135: SWI/SNF-related matrix-associated actin-dependent regul |
H3F3A |
H3F3A, H3.3A, PP781, H3.3B, H3F3B, H3F3: Histone H3.3 |
2.902 |
Evidence |
|
| CDKN1A |
CDKN1A, CAP20, CDKN1, CIP1, MDA6, PIC1, SDI1, WAF1: Cyclin-dependent kinase inhi |
CDC6 |
CDC6, CDC18L: Cell division control protein 6 homolog |
2.895 |
Evidence |
O
|
| SKIL |
SKIL, SNO: Ski-like protein |
SMAD1 |
SMAD1, BSP1, MADH1, MADR1: Mothers against decapentaplegic homolog 1 |
2.855 |
Evidence |
|
| UBE2N |
UBE2N, BLU: Ubiquitin-conjugating enzyme E2 N |
UBE2V2 |
UBE2V2, MMS2, UEV2: Ubiquitin-conjugating enzyme E2 variant 2 |
2.79 |
Evidence |
O
|
| SART1 |
SART1: U4/U6.U5 tri-snRNP-associated protein 1 |
UBL5 |
UBL5: Ubiquitin-like protein 5 |
2.645 |
Evidence |
|
| IGF1R |
IGF1R: Insulin-like growth factor 1 receptor precursor |
YWHAB |
YWHAB: 14-3-3 protein beta/alpha |
2.637 |
Evidence |
O
|
| BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
CREBBP |
CREBBP, CBP: CREB-binding protein |
2.595 |
Evidence |
O
|
